- NLS Pharmaceutics (NASDAQ:NLSP -1.8%) has announced that Chad C. Hellmann has been appointed to the position of Chief Financial Officer.
- Serving most recently as CFO and co-portfolio manager of Arcus Ventures, Mr. Hellmann brings to NLS significant expertise in developing and implementing operational strategies and capital markets solutions for life sciences companies.
- NLS also announces that Subhasis Roy has resigned as Interim CFO and will remain a consultant to the Co. through June 30, 2022 to assist with the CFO transition.